User profiles for "author:Madhu Mazumdar"

Madhu Mazumdar

Professor of Biostatistics, Icahn School of Medicine at Mount Sinai
Verified email at mountsinai.org
Cited by 40109

Endoscopic pituitary surgery: a systematic review and meta-analysis

A Tabaee, VK Anand, Y Barrón, DH Hiltzik… - Journal of …, 2009 - thejns.org
Object Surgery on the pituitary gland is increasingly being performed through an endoscopic
approach. However, there is little published data on its safety and relative advantages over …

Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision‐making about cancer treatments

M Mazumdar, JR Glassman - Statistics in medicine, 2000 - Wiley Online Library
Categorizing prognostic variables is essential for their use in clinical decision‐making. Often
a single cutpoint that stratifies patients into high‐risk and low‐risk categories is sought …

Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis

A Gupta, JL Chazen, M Hartman, D Delgado… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Impairments in cerebrovascular reserve (CVR) have been
variably associated with increased risk of ischemic events and may stratify stroke risk in …

[HTML][HTML] An inflammatory cytokine signature predicts COVID-19 severity and survival

DM Del Valle, S Kim-Schulze, HH Huang… - Nature medicine, 2020 - nature.com
Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …

[PDF][PDF] Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma

RJ Motzer, M Mazumdar, J Bacik, W Berg… - Journal of clinical …, 1999 - academia.edu
Purpose: To identify prognostic factors and a model predictive for survival in patients w ith
metastatic renalcell carcinoma (RCC). Patients and Methods: The relationship betw een …

[PDF][PDF] Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

RJ Motzer, J Bacik, BA Murphy… - Journal of …, 2002 - pfizerpro.com.s3.amazonaws.com
Purpose: To define outcome data and prognostic criteria for patients with metastatic renal
cell carcinoma (RCC) treated with interferon-alfa as initial systemic therapy. The data can be …

[PDF][PDF] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

RJ Motzer, J Bacik, LH Schwartz… - Journal of clinical …, 2004 - scholar.archive.org
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell
Carcinoma Page 1 Prognostic Factors for Survival in Previously Treated Patients With …

[PDF][PDF] DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia

ME Figueroa, S Lugthart, Y Li… - Cancer cell, 2010 - cell.com
We hypothesized that DNA methylation distributes into specific patterns in cancer cells,
which reflect critical biological differences. We therefore examined the methylation profiles of …

[PDF][PDF] Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

DF Bajorin, PM Dodd, M Mazumdar… - Journal of Clinical …, 1999 - scholar.archive.org
Purpose: The variation in reported survival of patients with metastatic transitional-cell
carcinoma (TCC) treated with systemic chemotherapy may be a consequence of …

Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in …

SM Larson, Y Erdi, T Akhurst, M Mazumdar… - Clinical Positron …, 1999 - Elsevier
“Functional” tumor treatment response parameters have been developed to measure
treatment induced biochemical changes in the entire tumor mass, using positron emission …